Steven Joffe, Deborah E Sellers, Lynette Ekunwe, Donna Antoine-Lavigne, Sarah McGraw, Daniel Levy, Greta Lee Splansky. Circ Genom Precis Med 2019
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
Return of genomic results to research participants: the floor, the ceiling, and the choices in between.
Gail P Jarvik, Laura M Amendola, Jonathan S Berg, Kyle Brothers, Ellen W Clayton, Wendy Chung, Barbara J Evans, James P Evans, Stephanie M Fullerton, Carlos J Gallego,[...]. Am J Hum Genet 2014
Gail P Jarvik, Laura M Amendola, Jonathan S Berg, Kyle Brothers, Ellen W Clayton, Wendy Chung, Barbara J Evans, James P Evans, Stephanie M Fullerton, Carlos J Gallego,[...]. Am J Hum Genet 2014
75
Communicating genetic and genomic information: health literacy and numeracy considerations.
D H Lea, K A Kaphingst, D Bowen, I Lipkus, D W Hadley. Public Health Genomics 2011
D H Lea, K A Kaphingst, D Bowen, I Lipkus, D W Hadley. Public Health Genomics 2011
50
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.
Richard R Fabsitz, Amy McGuire, Richard R Sharp, Mona Puggal, Laura M Beskow, Leslie G Biesecker, Ebony Bookman, Wylie Burke, Esteban Gonzalez Burchard, George Church,[...]. Circ Cardiovasc Genet 2010
Richard R Fabsitz, Amy McGuire, Richard R Sharp, Mona Puggal, Laura M Beskow, Leslie G Biesecker, Ebony Bookman, Wylie Burke, Esteban Gonzalez Burchard, George Church,[...]. Circ Cardiovasc Genet 2010
50
Biobank participants' preferences for disclosure of genetic research results: perspectives from the OurGenes, OurHealth, OurCommunity project.
Nicole L Allen, Elizabeth W Karlson, Susan Malspeis, Bing Lu, Christine E Seidman, Lisa Soleymani Lehmann. Mayo Clin Proc 2014
Nicole L Allen, Elizabeth W Karlson, Susan Malspeis, Bing Lu, Christine E Seidman, Lisa Soleymani Lehmann. Mayo Clin Proc 2014
50
Subjects matter: a survey of public opinions about a large genetic cohort study.
David Kaufman, Juli Murphy, Joan Scott, Kathy Hudson. Genet Med 2008
David Kaufman, Juli Murphy, Joan Scott, Kathy Hudson. Genet Med 2008
50
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
50
Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
Anna Middleton, Katherine I Morley, Eugene Bragin, Helen V Firth, Matthew E Hurles, Caroline F Wright, Michael Parker. Eur J Hum Genet 2016
Anna Middleton, Katherine I Morley, Eugene Bragin, Helen V Firth, Matthew E Hurles, Caroline F Wright, Michael Parker. Eur J Hum Genet 2016
50
Return of genetic and genomic research findings: experience of a pediatric biorepository.
Tanya Papaz, Eriskay Liston, Laura Zahavich, Dimitri J Stavropoulos, Rebekah K Jobling, Raymond H Kim, Miriam Reuter, Anastasia Miron, Erwin Oechslin, Tapas Mondal,[...]. BMC Med Genomics 2019
Tanya Papaz, Eriskay Liston, Laura Zahavich, Dimitri J Stavropoulos, Rebekah K Jobling, Raymond H Kim, Miriam Reuter, Anastasia Miron, Erwin Oechslin, Tapas Mondal,[...]. BMC Med Genomics 2019
50
Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues).
Christine Weiner. Am J Epidemiol 2014
Christine Weiner. Am J Epidemiol 2014
50
The research participant perspective related to the conduct of genomic cohort studies: A systematic review of the quantitative literature.
Deborah Goodman, Deborah Bowen, Lari Wenzel, Paris Tehrani, Francis Fernando, Araksi Khacheryan, Farihah Chowdhury, Catherine O Johnson, Karen Edwards. Transl Behav Med 2018
Deborah Goodman, Deborah Bowen, Lari Wenzel, Paris Tehrani, Francis Fernando, Araksi Khacheryan, Farihah Chowdhury, Catherine O Johnson, Karen Edwards. Transl Behav Med 2018
50
The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results.
Yvonne Bombard, Kyle B Brothers, Sara Fitzgerald-Butt, Nanibaa' A Garrison, Leila Jamal, Cynthia A James, Gail P Jarvik, Jennifer B McCormick, Tanya N Nelson, Kelly E Ormond,[...]. Am J Hum Genet 2019
Yvonne Bombard, Kyle B Brothers, Sara Fitzgerald-Butt, Nanibaa' A Garrison, Leila Jamal, Cynthia A James, Gail P Jarvik, Jennifer B McCormick, Tanya N Nelson, Kelly E Ormond,[...]. Am J Hum Genet 2019
50
Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve.
Bo Yang, Wei Zhou, Jiao Jiao, Jonas B Nielsen, Michael R Mathis, Mahyar Heydarpour, Guillaume Lettre, Lasse Folkersen, Siddharth Prakash, Claudia Schurmann,[...]. Nat Commun 2017
Bo Yang, Wei Zhou, Jiao Jiao, Jonas B Nielsen, Michael R Mathis, Mahyar Heydarpour, Guillaume Lettre, Lasse Folkersen, Siddharth Prakash, Claudia Schurmann,[...]. Nat Commun 2017
50
Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection.
Marjolijn Renard, Catherine Francis, Rajarshi Ghosh, Alan F Scott, P Dane Witmer, Lesley C Adès, Gregor U Andelfinger, Pauline Arnaud, Catherine Boileau, Bert L Callewaert,[...]. J Am Coll Cardiol 2018
Marjolijn Renard, Catherine Francis, Rajarshi Ghosh, Alan F Scott, P Dane Witmer, Lesley C Adès, Gregor U Andelfinger, Pauline Arnaud, Catherine Boileau, Bert L Callewaert,[...]. J Am Coll Cardiol 2018
50
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
50
Returning genomic results in a Federally Qualified Health Center: the intersection of precision medicine and social determinants of health.
Gabriel Q Shaibi, Iftikhar J Kullo, Davinder P Singh, Valentina Hernandez, Richard R Sharp, Idali Cuellar, Eleanna De Filippis, Sharon Levey, Carmen Radecki Breitkopf, Lawrence J Mandarino,[...]. Genet Med 2020
Gabriel Q Shaibi, Iftikhar J Kullo, Davinder P Singh, Valentina Hernandez, Richard R Sharp, Idali Cuellar, Eleanna De Filippis, Sharon Levey, Carmen Radecki Breitkopf, Lawrence J Mandarino,[...]. Genet Med 2020
50
Knowledge and understanding of pharmacogenomic testing among patients and health care professionals: A scoping review.
Sophie Veilleux, Maud Bouffard. Patient Educ Couns 2019
Sophie Veilleux, Maud Bouffard. Patient Educ Couns 2019
100
Consumers' views of pharmacogenetics--A qualitative study.
Catherine A Haddy, Helena M Ward, Manya T Angley, Ross A McKinnon. Res Social Adm Pharm 2010
Catherine A Haddy, Helena M Ward, Manya T Angley, Ross A McKinnon. Res Social Adm Pharm 2010
25
Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.
Helle Vendel Petersen, Birgitte Lidegaard Frederiksen, Charlotte Kvist Lautrup, Lars Joachim Lindberg, Steen Ladelund, Mef Nilbert. Fam Cancer 2019
Helle Vendel Petersen, Birgitte Lidegaard Frederiksen, Charlotte Kvist Lautrup, Lars Joachim Lindberg, Steen Ladelund, Mef Nilbert. Fam Cancer 2019
25
Disclosure of individual pharmacogenomic results in research projects: when and what kind of information to return to research participants.
Sandra Korol, Thierry Hurlimann, Béatrice Godard, Simon de Denus. Pharmacogenomics 2013
Sandra Korol, Thierry Hurlimann, Béatrice Godard, Simon de Denus. Pharmacogenomics 2013
25
Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
Sony Tuteja, Kevin Haynes, Cara Zayac, Jon E Sprague, Barbara Bernhardt, Reed Pyeritz. Per Med 2013
Sony Tuteja, Kevin Haynes, Cara Zayac, Jon E Sprague, Barbara Bernhardt, Reed Pyeritz. Per Med 2013
25
25
Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
Larissa Waldman, Cheryl Shuman, Iris Cohn, Amy Kaiser, David Chitayat, Syed Wasim, Allison Hazell. Pharmacogenomics 2019
Larissa Waldman, Cheryl Shuman, Iris Cohn, Amy Kaiser, David Chitayat, Syed Wasim, Allison Hazell. Pharmacogenomics 2019
33
Limitations and Pitfalls of Using Family Letters to Communicate Genetic Risk: a Qualitative Study with Patients and Healthcare Professionals.
Sandi Dheensa, Anneke Lucassen, Angela Fenwick. J Genet Couns 2018
Sandi Dheensa, Anneke Lucassen, Angela Fenwick. J Genet Couns 2018
25
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Ursula Amstutz, Linda M Henricks, Steven M Offer, Julia Barbarino, Jan H M Schellens, Jesse J Swen, Teri E Klein, Howard L McLeod, Kelly E Caudle, Robert B Diasio,[...]. Clin Pharmacol Ther 2018
Ursula Amstutz, Linda M Henricks, Steven M Offer, Julia Barbarino, Jan H M Schellens, Jesse J Swen, Teri E Klein, Howard L McLeod, Kelly E Caudle, Robert B Diasio,[...]. Clin Pharmacol Ther 2018
25
Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.
Colin Me Halverson, Kristin E Clift, Jennifer B McCormick. J Community Genet 2016
Colin Me Halverson, Kristin E Clift, Jennifer B McCormick. J Community Genet 2016
25
Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
25
Assessing Genetic Literacy Awareness and Knowledge Gaps in the US Population: Results from the Health Information National Trends Survey.
Melinda Krakow, Chelsea L Ratcliff, Bradford W Hesse, Alexandra J Greenberg-Worisek. Public Health Genomics 2017
Melinda Krakow, Chelsea L Ratcliff, Bradford W Hesse, Alexandra J Greenberg-Worisek. Public Health Genomics 2017
25
Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
K Aktan-Collan, A Haukkala, K Pylvänäinen, H J Järvinen, L A Aaltonen, P Peltomäki, E Rantanen, H Kääriäinen, J-P Mecklin. J Med Genet 2007
K Aktan-Collan, A Haukkala, K Pylvänäinen, H J Järvinen, L A Aaltonen, P Peltomäki, E Rantanen, H Kääriäinen, J-P Mecklin. J Med Genet 2007
25
What Results Should Be Returned from Opportunistic Screening in Translational Research?
Colin Me Halverson, Sarah H Jones, Laurie Novak, Christopher Simpson, Digna R Velez Edwards, Sifang Kathy Zhao, Ellen W Clayton. J Pers Med 2020
Colin Me Halverson, Sarah H Jones, Laurie Novak, Christopher Simpson, Digna R Velez Edwards, Sifang Kathy Zhao, Ellen W Clayton. J Pers Med 2020
25
Preliminary report of the relationship between experience of death of a relative, illness perception, and psychological outcome among BRCA carriers.
Dikla Samama, Ilanit Hasson-Ohayon, Shlomit Perry, Ofir Morag, Gil Goldzweig. Psychol Health Med 2014
Dikla Samama, Ilanit Hasson-Ohayon, Shlomit Perry, Ofir Morag, Gil Goldzweig. Psychol Health Med 2014
25
Return of research results from pharmacogenomic versus disease susceptibility studies: what's drugs got to do with it?
Lynn G Dressler. Pharmacogenomics 2012
Lynn G Dressler. Pharmacogenomics 2012
25
Family stories and the use of heuristics: women from suspected hereditary breast and ovarian cancer (HBOC) families.
Regina Kenen, Audrey Ardern-Jones, Rosalind Eeles. Sociol Health Illn 2003
Regina Kenen, Audrey Ardern-Jones, Rosalind Eeles. Sociol Health Illn 2003
25
Improving safety of fluoropyrimidine chemotherapy by individualizing treatment based on dihydropyrimidine dehydrogenase activity - Ready for clinical practice?
Didier Meulendijks, Annemieke Cats, Jos H Beijnen, Jan H M Schellens. Cancer Treat Rev 2016
Didier Meulendijks, Annemieke Cats, Jos H Beijnen, Jan H M Schellens. Cancer Treat Rev 2016
25
Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
Yee Ming Lee, Ryan P McKillip, Brittany A Borden, Catherine E Klammer, Mark J Ratain, Peter H O'Donnell. Pharmacogenet Genomics 2017
Yee Ming Lee, Ryan P McKillip, Brittany A Borden, Catherine E Klammer, Mark J Ratain, Peter H O'Donnell. Pharmacogenet Genomics 2017
25
'Well, I knew this already' - explaining personal genetic risk information through narrative meaning-making.
Karoliina Snell, Ilpo Helén. Sociol Health Illn 2020
Karoliina Snell, Ilpo Helén. Sociol Health Illn 2020
33
Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study.
Kevin Sweet, Shelly Hovick, Amy C Sturm, Tara Schmidlen, Erynn Gordon, Barbara Bernhardt, Lisa Wawak, Karen Wernke, Joseph McElroy, Laura Scheinfeldt,[...]. J Genet Couns 2017
Kevin Sweet, Shelly Hovick, Amy C Sturm, Tara Schmidlen, Erynn Gordon, Barbara Bernhardt, Lisa Wawak, Karen Wernke, Joseph McElroy, Laura Scheinfeldt,[...]. J Genet Couns 2017
25
"Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic Testing.
Susan Brown Trinidad, Tara B Coffin, Stephanie M Fullerton, James Ralston, Gail P Jarvik, Eric B Larson. Perm J 2015
Susan Brown Trinidad, Tara B Coffin, Stephanie M Fullerton, James Ralston, Gail P Jarvik, Eric B Larson. Perm J 2015
25
The Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading ability.
Nancy S Morris, Charles D MacLean, Lisa D Chew, Benjamin Littenberg. BMC Fam Pract 2006
Nancy S Morris, Charles D MacLean, Lisa D Chew, Benjamin Littenberg. BMC Fam Pract 2006
25
Collaborative Counseling Considerations for Pharmacogenomic Tests.
Heather A Zierhut, Colleen A Campbell, Allison G Mitchell, Amy A Lemke, Rachel Mills, Jeffrey R Bishop. Pharmacotherapy 2017
Heather A Zierhut, Colleen A Campbell, Allison G Mitchell, Amy A Lemke, Rachel Mills, Jeffrey R Bishop. Pharmacotherapy 2017
25
Participants' recall and understanding of genomic research and large-scale data sharing.
Jill Oliver Robinson, Melody J Slashinski, Tao Wang, Susan G Hilsenbeck, Amy L McGuire. J Empir Res Hum Res Ethics 2013
Jill Oliver Robinson, Melody J Slashinski, Tao Wang, Susan G Hilsenbeck, Amy L McGuire. J Empir Res Hum Res Ethics 2013
25
'Science is really needed--that's all I know': informed consent and the non-verbal practices of collecting blood for genetic research in northern Sweden.
Klaus Hoeyer. New Genet Soc 2003
Klaus Hoeyer. New Genet Soc 2003
25
Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care.
Didier Meulendijks, J G Coen van Hasselt, Alwin D R Huitema, Harm van Tinteren, Maarten J Deenen, Jos H Beijnen, Annemieke Cats, Jan H M Schellens. Eur J Cancer 2016
Didier Meulendijks, J G Coen van Hasselt, Alwin D R Huitema, Harm van Tinteren, Maarten J Deenen, Jos H Beijnen, Annemieke Cats, Jan H M Schellens. Eur J Cancer 2016
25
The return of unexpected research results in a biobank study and referral to health care for heritable long QT syndrome.
A Haukkala, E Kujala, P Alha, V Salomaa, S Koskinen, H Swan, H Kääriäinen. Public Health Genomics 2013
A Haukkala, E Kujala, P Alha, V Salomaa, S Koskinen, H Swan, H Kääriäinen. Public Health Genomics 2013
25
An update to returning genetic research results to individuals: perspectives of the industry pharmacogenomics working group.
Sandra K Prucka, Lester J Arnold, John E Brandt, Sandra Gilardi, Lea C Harty, Feng Hong, Joanne Malia, David J Pulford. Bioethics 2015
Sandra K Prucka, Lester J Arnold, John E Brandt, Sandra Gilardi, Lea C Harty, Feng Hong, Joanne Malia, David J Pulford. Bioethics 2015
25
Patient and Health Care Provider Needs and Preferences in Understanding Pharmacogenomic and Genomic Testing: A Meta-Data Analysis.
Sophie Veilleux, Maud Bouffard, Mijanou Bourque Bouliane. Qual Health Res 2020
Sophie Veilleux, Maud Bouffard, Mijanou Bourque Bouliane. Qual Health Res 2020
25
Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy.
Annelien L Bredenoord, N Charlotte Onland-Moret, Johannes J M Van Delden. Hum Mutat 2011
Annelien L Bredenoord, N Charlotte Onland-Moret, Johannes J M Van Delden. Hum Mutat 2011
25
Return of individual research results and incidental findings: facing the challenges of translational science.
Susan M Wolf. Annu Rev Genomics Hum Genet 2013
Susan M Wolf. Annu Rev Genomics Hum Genet 2013
25
25
[Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].
Marie-Anne Loriot, Joseph Ciccolini, Fabienne Thomas, Chantal Barin-Le-Guellec, Bernard Royer, Gérard Milano, Nicolas Picard, Laurent Becquemont, Céline Verstuyft, Céline Narjoz,[...]. Bull Cancer 2018
Marie-Anne Loriot, Joseph Ciccolini, Fabienne Thomas, Chantal Barin-Le-Guellec, Bernard Royer, Gérard Milano, Nicolas Picard, Laurent Becquemont, Céline Verstuyft, Céline Narjoz,[...]. Bull Cancer 2018
25
Engaging Hmong adults in genomic and pharmacogenomic research: Toward reducing health disparities in genomic knowledge using a community-based participatory research approach.
Kathleen A Culhane-Pera, Robert J Straka, MaiKia Moua, Youssef Roman, Pachia Vue, Kang Xiaaj, May Xia Lo, Mai Lor. J Community Genet 2017
Kathleen A Culhane-Pera, Robert J Straka, MaiKia Moua, Youssef Roman, Pachia Vue, Kang Xiaaj, May Xia Lo, Mai Lor. J Community Genet 2017
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.